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Background: “Hypertriglyceridemic waist” (HTGW) phenotype, an inexpensive early screening tool for detection of
individuals at risk for type 2 diabetes and cardiovascular disease was found to be associated with subclinical
atherosclerosis in various patient populations such as those with diabetes mellitus, chronic kidney disease, and
those infected with human immunodeficiency virus. However, less is known regarding an association between
HTGW and subclinical atherosclerosis in the apparently healthy, multiethnic population. Therefore, the aim of the
study was to explore the association between HTGW and sub-clinical atherosclerosis in an apparently healthy,
multiethnic population; and to investigate whether the effect of HTGW on sub-clinical atherosclerosis persists over
and above the traditional atherosclerosis risk factors.
Methods: We studied 809 individuals of Aboriginal, Chinese, European and South Asian origin who were assessed
for indices of sub-clinical atherosclerosis (intima-media thickness (IMT), total area and presence of carotid plaques),
socio-demographic and lifestyle characteristics, anthropometrics, lipids, glucose, blood pressure, and family history
of cardiovascular disease.
Results: We found that, compared to individuals without HTGW and after adjusting for age, ethnicity, smoking, and
physical activity; men and women with HTGW had a significantly higher: IMT (men: B (95%CI = 0.084 (0.037, 1.133),
p < 0.001; women: B (95%CI) = 0.041 (0.006, 0.077), p = 0.020); and total area (men: B (95%CI = 0.202 (0.058, 0.366),
p = 0.005; women: B (95%CI) = 0.115 (0.006, 0.235), p = 0.037). The association between HTGW waist and presence of
plaques was significant for men (OR (95%CI) = 1.904 (1.040, 3.486), p = 0.037 vs. men without HTGW), but not for
women (p = 0.284). Once analyses were adjusted for additional, traditional risk factors for atherosclerosis, the effect
of HTGW on sub-clinical atherosclerosis was no longer significant.
Conclusions: In conclusion, HTGW may serve as an early marker of subclinical atherosclerosis in men and women,
irrespective of ethnicity. However, once individuals are assessed for all traditional risk factors for atherosclerosis, the
additional assessment for HTGW is not warranted.
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Atherosclerosis is a chronic progressive disease associated
with high cardiovascular morbidity and mortality [1]. The
diagnosis of atherosclerosis in its subclinical stage (sub-
clinical atherosclerosis) is important, as it would allow for
early implementation of lifestyle prevention programs that
may help prevent further progression and cardiovascular
events [2]. Various invasive and non-invasive arterial
imaging techniques (such as intravascular sonography,
B-mode ultrasonography, computed tomography and
magnetic imaging) have been developed to detect and
diagnose sub-clinical atherosclerosis [1]. A commonly
used technique is a non-invasive B-mode ultrasonography
that can determine the thickness of the intima-media
layers (intima-media thickness, IMT) and characterize
focal plaques. Thus, IMT carotid ultrasound is an estab-
lished non-invasive method for detection of early ath-
erosclerotic disease [3]. Longitudinal studies have shown
a strong association between IMT and future risk of myo-
cardial infarction and stroke [3,4], while in clinical trials
IMT is often used to evaluate the effects of coronary
heart disease risk factor interventions on atherosclerotic
burden [5].
Obesity, an independent predictor of cardiovascular
disease (CVD) [6,7] has been found to be associated with
abnormal IMT. Namely, positive associations were re-
ported between IMT and general obesity as measured by
body mass index (BMI) [8], as well as between IMT and
abdominal obesity as depicted by waist circumference
(WC) and waist-to-hip ratio [8-10] or visceral adipose tis-
sue [11]. Moreover, “hypertriglyceridemic waist” (HTGW)
phenotype, an inexpensive early screening tool for detec-
tion of individuals at risk for type 2 diabetes and CVD that
takes into account WC and fasting triglycerides (TG)
[12-14] was found to be associated with subclinical athero-
sclerosis in various patient populations such as those with
diabetes mellitus [15,16], chronic kidney disease [17], and
those infected with human immunodeficiency virus [18].
However, less is known regarding an association between
HTGW and subclinical atherosclerosis in the apparently
healthy, multiethnic population. Therefore, the purpose of
this study was to investigate whether HTGW is associated
with measures of sub-clinical atherosclerosis (IMT, pres-
ence of plaques, and total area (a composite of IMT and
plaque area)) in a multi-ethnic primary prevention cohort
of men and women without pre-existing diabetes or
CVD; and to explore whether this association remains
after taking into account the traditional risk factors for
atherosclerosis.
Methods
Study population
Individuals were recruited as part of the Multi-Cultural
Community Health Assessment Trial (M-CHAT), a studyinitially designed to investigate ethnic differences in body
fat accumulation and how these relate to diabetes and
CVD risk [19]. Men and women of self-reported Abori-
ginal, Chinese, European, and South Asian origin be-
tween 30 and 65 years of age, with no weight change of
more than 2 kg in three months before assessment date,
and with no diagnosed CVD or on medications to treat
CVD-related risk factors were eligible to participate in
the study. Individuals of Chinese, European, and South
Asian origin had to be living in Canada for more than
three years and had to be third-generation Canadian or
less in order to limit possible differences in acculturation
among the immigrant groups. Individuals of Aboriginal
origin were eligible for the study if they reported to have
at least three grandparents of exclusive Aboriginal descent.
Within each ethnic group, participants were recruited
across ranges of BMI (≤24.9 (lower range), 25.0-29.9 (mid-
dle range) and ≥30 (upper range)) to examine CVD associ-
ations within a range of body sizes. However, there was a
difficulty in identifying Aboriginal men with a BMI of less
than 25, so Aboriginal men of any BMI were recruited.
Similarly, we encountered a difficulty in the recruitment
of Chinese individuals with a BMI of 30 and over; there-
fore, the target for the upper BMI range for Chinese study
participants was changed to a BMI ≥28. Despite these
modifications, the study multiethnic cohort had suffi-
cient variation in BMI values within each ethnic group.
All participants provided written informed consent for
the study, and the study was approved by the Simon
Fraser University Research Ethics Board.
Participant assessment
Study participants were assessed for demographics, an-
thropometry, health-related behaviours, lipids, and sub-
clinical atherosclerosis. Body mass index was calculated
as weight in kilograms divided by height in metres
squared. Waist circumference was measured at the
point of maximal narrowing of the waist, and an average
of two measures was calculated and recorded in centi-
metres. Smoking status (smoker vs. former smoker/never
smoker) was self-reported. Physical activity was deter-
mined by self-report, measured using the Modifiable
Physical Activity questionnaire previously used in multi-
ethnic populations [20,21], and reported as the average
minutes per week of leisure physical activity over the pre-
vious year. A fasting blood sample was obtained from each
study participant, and TG were measured using a standard
protocol by the ADVIA 1650 analyzer (Bayer Health Care,
Morristown, NJ). The HTGW phenotype was defined as
WC ≥ 85 cm and TG ≥ 1.5 mmol/L in females, and
WC ≥ 90 cm and TG ≥ 2.0 mmol/L in males [22].
Average carotid IMT, total area, and presence of pla-
ques were assessed as indices of sub-clinical athero-
sclerosis as previously described [23]. Briefly, carotid
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formed at the Prevention Clinic/Healthy Heart Program
at St. Paul’s Hospital in Vancouver, Canada. Carotid arter-
ies were examined bilaterally using a 7.5 MHz to 10 MHz
linear-array transducer (Image Point HX, Hewlett Packard,
Andover, MA), and individual IMT measurements were
taken over a 10 mm segment in the far wall of the right
and left common coronary carotid artery within 2 cm
proximal to the carotid bulb. The region with the thickest
IMT, excluding areas with focal lesions, was measured. All
scans were thereafter transferred to the Cardiovascular
Imaging Research Core Laboratory at Vancouver General
Hospital to be digitized for analysis (Vascular Imager
5.0, Medical Imaging Applications, LLC, Coralville, IA).
The average IMT (mm) was derived from the right and
left IMT measurements. Plaques in any of the carotid
segments were measured. Plaques were identified, by
consensus of at least 2 observers, as wall thickness that
was increased focally compared with IMT on either side
of the focal area. Total area (mm2), a superior measure
of atherosclerotic burden than IMT alone [23], was cal-
culated as the sum of IMT area (20 mm length x average
IMT for the measured length (mm)) and plaque area.
Plaque area was equal to the average lesion thickness
(mm) multiplied by lesion length (mm)). In case of mul-
tiple plaques, average plaque thickness was calculated
by dividing the area of plaques (area of plaque 1 + area
of plaque 2 +…) by the total length of plaques (length
of plaque 1 + length of plaque 2 +…). The intraclass and
interobserver correlation values for this method were
0.922 to 0.948 and 0.850 to 0.901, respectively [23]. For
repeated measures in the same subject, the accuracy
and precision were −0.001 mm (not significant com-
pared to 0.00 mm) and 0.04 mm, respectively, for IMT
and −0.21 mm2 (not significant compared to 0.00 mm2)
and 3.61 mm2, respectively, for total area. Of importance,
given that our study population consisted of apparently
healthy individuals, about 50 percent of participants had no
detectible plaques. Consequently, instead of plaque size, we
used presence of plaques variable (any plaque present
vs. plaques not present) as an outcome variable to iden-
tify whether HTGW shows any association with plaque
presence in this multiethnic study population.
Statistical analyses
Out of 822 participants initially recruited for the M-CHAT
study, 13 participants were missing data for measures
of sub-clinical atherosclerosis. These individuals were
excluded from the study, and the final sample consisted
of 809 participants. Distribution of all continuous variables
was explored for normality, and non-normally distributed
variables (IMT, total area, TG, physical activity, fasting
blood glucose, and systolic blood pressure) were trans-
formed using the natural logarithm. Sex differences instudy characteristics were explored using an independ-
ent t-test for continuous variables and Chi-square test
for categorical variables. The differences in study char-
acteristics among individuals were stratified as follows:
1) Without HTGW (WC and TG not elevated); 2) Elevated
TG (not elevated WC); 3) Elevated WC (not elevated TG)
and 4) HTGW (elevated both TG and WC). These were
analyzed using general linear models and Chi-square tests
for continuous and categorical variables, respectively.
Multiple linear regression analyses were used to explore
the association of the stratified HTGW components with
IMT and total area. Logistic regression analysis was uti-
lized to explore the association between the stratified
HTGW components and presence of plaques. Given that
there was a significant interaction between the effect of
sex and effect of HTGW on IMT (p = 0.013), all regression
models were performed for men and women separately.
However, no significant interaction between the effect
of ethnicity and effect of HTGW on IMT was observed
(p = 0.329), therefore, the analyses were not additionally
stratified by ethnic group. All regression models were
adjusted for age, ethnicity, smoking and physical activ-
ity. In order to explore whether the association between
HTGW and indices of sub-clinical atherosclerosis re-
mains after the adjustment for additional, traditional
risk factors for atherosclerosis, the analyses were further
adjusted for total cholesterol, high-density lipoprotein
cholesterol (HDL-C), fasting blood glucose, systolic blood
pressure and BMI. Regression models were explored for
multicollinearity, and variance inflation indices and toler-
ance statistics indicate no multicollinearity in our data. All
analyses were performed using Statistical Package for
Social Sciences 19 (SPSS, Chicago, IL). P values ≤ 0.05
were considered significant.
Results
Baseline characteristics of male and female participants
are shown in Table 1. Significantly higher cardiovascular
risk was seen among men demonstrated by larger WC,
higher levels of TG, fasting blood glucose and systolic
blood pressure, greater prevalence of HTGW, HDL-C,
greater average carotid IMT, and larger total area. Further-
more, compared to women, men were more likely to have
plaques present in carotid arteries.
Characteristics of participating men, stratified by the
presence of HTGW components, are presented in Table 2.
In men, HTGW phenotype was most prevalent among
South Asians (32.1%) and least prevalent among Chinese
(17.9%). Furthermore, the greatest percentage of men
without HTGW was highest among Chinese (37.3%)
which was more than three times higher than that of
Aboriginals. However, prevalence of Elevated TG pheno-
type was about 20 times higher in Chinese men compared
to their Aboriginal and European counterparts. Highest
Table 1 Baseline characteristics of the study population
Characteristic Men
n = 391
Women
n = 418
Significance (p)
Age 46.6 ± 8.7 47.5 ± 8.8 0.130
Ethnicity 0.885
Aboriginal 90 (23.0%) 101 (24.2%)
Chinese 101 (25.8%) 115 (27.5%)
European 98 (25.1%) 99 (23.7%)
South Asian 102 (26.1%) 103 (24.6%)
Current smoker 50 (12.8%) 38 (9.1%) 0.058
Family history of
CVD present (%)
171 (43.7%) 186 (44%) 0.827
Physical activity
(min/week)
225 (97, 444) 208 (95, 413) 0.171
BMI 27.6 ± 4.3 27.4 ± 5.2 0.520
Waist circumference
(cm)
92.7 ± 11.1 85.3 ± 12.1 < 0.001
Total cholesterol
(mmol/L)
5.25 ± 0.97 5.24 ± 1.03 0.925
HDL-C (mmol/L) 1.13 ± 0.29 1.43 ± 0.36 < 0.001
Triglycerides
(mmol/L)
1.47 (0.99, 2.23) 1.18 (0.83, 1.63) < 0.001
Without HTGW 134 (35.5%) 168 (40.8%) 0.008
Elevated TG 31 (8.2%) 57 (13.8%)
Elevated WC 128 (34.0%) 117 (28.4%)
HTGW 84 (22.3%) 70 (17%)
Glucose (mmol/L) 5.30 (5.00, 5.60) 5.10 (4.80, 5.40) < 0.001
Systolic blood
pressure (mm Hg)
117 (110, 124) 115 (106, 125) 0.035
Intima-media
thickness (mm)
0.68 (0.60, 0.77) 0.63 (0.58, 0.70) < 0.001
Total area (mm2) 16.60
(13.14, 23.99)
14.24
(12.00, 20.51)
< 0.001
Presence of plaque 213 (54.5%) 191 (45.7%) 0.008
Categorical variables presented as n (%). Normally distributed continuous
variables presented as mean ± SD. Skewed continuous variables presented as
median (25%, 75%). Sex differences in continuous and categorical variables
explored by independent t-test and Chi-square test, respectively. HDL-C: high-
density lipoprotein cholesterol; CVD: cardiovascular disease.
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and lowest HDL-C were observed among men with
HTGW. In addition, IMT and total area were signifi-
cantly higher in men with HTGW and Elevated WC
phenotypes compared to their counterparts without
HTGW and those with Elevated TG.
Characteristics of participating women, stratified by
the presence of HTGW components, are presented in
Table 3. Ethnic differences in the distribution of HTGW
components in women were similar to those in men with
the highest prevalence of Without HTGW and lowest
prevalence of HTGW phenotypes being among Chinese
women. Women with HTGW were about 5 times morelikely to smoke compared to women without HTGW. In
addition, BMI, fasting blood glucose, systolic blood pres-
sure, IMT and total area were significantly higher, while
HDL-C was significantly lower, in women with HTGW
than in those without HTGW.
The association of HTGW with indices of sub-clinical
atherosclerosis among men after adjusting for age, eth-
nicity, smoking, and physical activity is presented in
Figure 1. Intima-media thickness was significantly higher
in men with Elevated WC (B (95%CI = 0.059 (0.017,
0.102), p = 0.005) and with HTGW (B (95%CI = 0.084
(0.037, 1.133), p < 0.001) compared to their counterparts
without HTGW. Similarly, larger total area (a composite
of IMT and plaque area) was observed among men with
Elevated WC ((B (95%CI = 0.124 (0.001, 0.261), p = 0.047)
and HTGW ((B (95%CI = 0.202 (0.058, 0.366), p = 0.005)
then among men without HTGW. No statistically signifi-
cant difference in IMT and total area was observed be-
tween men with Elevated TG and those without HTGW.
Moreover, while no difference in prevalence of carotid
artery plaques was noted between men without HTGW
and those with Elevated TG and Elevated WC; prevalence
of carotid artery plaques was significantly higher among
men with HTGW than among their counterparts without
HTGW (OR (95%CI) = 1.904 (1.040, 3.486), p = 0.037).
However, after additional adjustment for total cholesterol,
HDL-C, glucose, systolic blood pressure, BMI, and family
history of CVD, traditional risk factors for atherosclerosis,
the association of HTGW with indices of atherosclerosis
was no longer significant (Additional file 1).
Figure 2 features the association of HTGW with indices
of sub-clinical atherosclerosis in women. After adjusting
for age, ethnicity, smoking, and physical activity, IMT
was significantly higher in women with Elevated TG (B
(95%CI) = 0.051 (0.013, 0.090), p = 0.007), Elevated WC
(B (95%CI) = 0.045 (0.015, 0.077), p = 0.003), and HTGW
(B (95%CI) = 0.041 (0.006, 0.077), p = 0.020) than in women
Without HTGW. Furthermore, total area of women with
HTGW was significantly larger than that among women
Without HTGW (B (95%CI) = 0.115 (0.006, 0.235), p =
0.037). However, no significant difference in total area was
found between women with Elevated TG and Elevated
WC and women Without HTGW. Additionally, presence
of carotid artery plaques among women with Elevated TG,
Elevated WC and HTGW did not significantly differ from
their counterparts Without HTGW. Once analyses were
additionally adjusted for traditional risk factors for athero-
sclerosis, HTGW phenotype was no longer associated
with IMT and total area (Figure 2, Additional file 2).
Discussion
In an apparently healthy multi-ethnic population of Abori-
ginal, Chinese, European and South Asian men and
women, we explored the association between HTGW
Table 2 Characteristics of participating men stratified by presence of HTGW components**
Characteristic Without HTGW
n = 134
Elevated TG
n = 31
Elevated WC
n = 128
HTGW
n = 84
Overall significance (p)
Age (years) 46.7 ± 8.9 46.1 ± 7.9 47.9 ± 8.7 45.5 ± 8.8 0.256
Ethnicity < 0.001
Aboriginal 15 (11.2%) 1 (3.2%) 38 (29.7%) 25 (29.8%)
Chinese 50 (37.3%) 19 (61.3%) 16 (12.5%) 15 (17.9%)
European 40 (29.9%) 1 (3.2%) 39 (30.5%) 17 (20.2%)
South Asian 29 (21.6%) 10 (32.3%) 35 (27.3%) 27 (32.1%)
Current smoker 10 (7.5%) 3 (9.7%) 14 (10.9%) 15 (17.9%) 0.125
Family history of CVD present (%) 59 (44.0%) 14 (45.2%) 58 (45.3%) 36 (42.9%) 0.987
Physical activity (min/week)*† 238 (194, 290) 153 (99, 236) 220 (179, 272) 183 (142, 236) 0.249
Body mass index* 24.2 (23.6, 24.7) 24.7 (23.6, 25.8) 29.8 (29.2, 30.3) 30.7 (30.1, 31.4) < 0.001b, c, d, e, f
Total cholesterol (mmol/L)* 5.11 ± 0.95 5.81 ± 1.01 5.00 ± 0.87 5.66 ± 0.95 < 0.001a, c, d, f
HDL-C (mmol/L)* 1.28 ± 0.30 0.97 ± 0.19 1.13 ± 0.27 0.94 ± 0.20 < 0.001a, b, c, d, f
Glucose (mmol/L)* 5.10 (4.90, 5.43) 5.20 (5.00, 5.40) 5.30 (5.10, 5.70) 5.60 (5.20, 5.90) < 0.001b, c, e, f
Systolic blood pressure (mm Hg)* 115 (108, 120) 116 (108, 124) 118 (112, 126) 120 (114, 131) 0.014c
Intima-media thickness (mm)*† 0.67 (0.65, 0.69) 0.65 (0.61, 0.69) 0.71 (0.69, 0.73) 0.72 (0.70, 0.75) < 0.001b, c, d, e
Total area (mm2)*† 17.87 (16.53, 19.34) 18.56 (15.75, 21.85) 20.41 (18.84, 21.85) 21.05 (19.07, 23.27) < 0.001b, c
Presence of plaque 66 (49.3%) 17 (54.8%) 74 (57.8%) 53 (63.1%) 0.225
*Age adjusted, presented as mean (95%CI), † geometric means; age presented as mean ± SD; Differences in continuous variables across categories of HTGW
components variable explored by general linear modelling. Categorical variables presented as n (%). Associations between categorical variables and HTGW
components variable explored by Chi-square test.
Pairwise comparisons: ap < 0.05, Normal WC/Normal TG vs. Elevated TG/Normal WC; bp < 0.05, Normal WC/Normal TG vs. Elevated WC/Normal TG; cp < 0.05,
Normal WC/Normal TG vs. HTGW; dp < 0.05, Elevated TG/Normal WC vs. Elevated WC/Normal TG; ep < 0.05, Elevated TG/Normal WC vs. HTGW; fp < 0.05, Elevated
WC/Normal TG vs. HTGW.
**Elevated waist circumference (WC) was ≥ 90 cm. Elevated triglyceride (TG) levels were ≥ 2 mmol/L. Fourteen male participants are missing data for one or both
hypertriglyceridemic waist (HTGW) components.
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of our study indicate that HTGW was significantly and
positively associated with IMT and total area in both men
and women. The positive association between HTGW and
presence of plaques was significant for men; but it did not
reach statistical significance for women. Significant associ-
ations between HTGW and indices of subclinical athero-
sclerosis were independent of age, ethnicity, smoking
behaviour, and levels of physical activity. However, once
analyses were adjusted for all traditionally measured risk
factors for atherosclerosis, the associations of HTGW
with indices of subclinical atherosclerosis were no longer
significant.
Our study is congruent with studies performed in pop-
ulations with diabetes mellitus [15,16], chronic kidney
disease [17], and those infected with human immuno-
deficiency virus [18] that found a positive association
between HTGW and subclinical atherosclerosis. In our
study, as indicated by total area and presence of plaques,
individuals with either Elevated WC or Elevated TG had
more carotid atherosclerosis than individuals without
HTGW; while greatest carotid atherosclerosis was ob-
served among men and women with HTGW suggesting
that the combination of a large WC and elevated TGresults in greater CVD risk. Indeed, the phenotype of
HTGW has previously been shown to be associated with
elevated cardiometabolic risk factors [13,24-28]. Addition-
ally, multiple prospective studies reported an increase in
risk of developing cardiovascular disease [22,29-31] and
diabetes [32,33] among individuals with HTGW pheno-
type further highlighting the utility of HTGW as a pre-
ventative screening tool.
It has been proposed that elevated fasting TG, in the
presence of increased WC, represent a marker of indi-
vidual’s relative inability to store energy surplus in the
subcutaneous adipose tissue (a protective metabolic sink);
consequently, HTGW could be a simple marker of vis-
ceral adipose tissue (dysfunctional adipose tissue) and
its metabolic complications resulting from insulin re-
sistance [14,34]. Indeed, it has recently been reported
that, among subjects with type 2 diabetes, HTGW iden-
tifies subset of individuals with greater degree of vis-
ceral adiposity and subclinical atherosclerosis (15). Of
importance, although there is an established link be-
tween insulin resistance and coronary artery disease
(CAD) [35], presence of HTGW was found to be asso-
ciated with increased CAD risk in both normoglycemic
and insulin resistant individuals [36].
Table 3 Characteristics of participating women stratified by presence of HTGW components**
Characteristic Without HTGW
n = 168
Elevated TG
n = 57
Elevated WC
n = 117
HTGW
n = 70
Overall significance (p)
Age (years) 48.1 ± 8.8 47.6 ± 9.7 47.3 ± 8.6 46.9 ± 8.8 0.795
Ethnicity < 0.001
Aboriginal 19 (11.3%) 12 (21.1%) 46 (39.3%) 21 (30.0%)
Chinese 61 (36.3%) 21 (36.8%) 24 (20.5%) 9 (12.9%)
European 43 (25.6%) 6 (10.5%) 27 (23.1%) 21 (30.0%)
South Asian 45 (26.8%) 18 (31.6%) 20 (17.1%) 19 (27.1%)
Current smoker 7 (4.2%) 4 (7.0%) 10 (8.5%) 14 (20.0%) 0.001
Family history of CVD present (%) 79 (47.0%) 25 (43.9%) 48 (41.0%) 31 (44.3%) 0.798
Physical activity (min/week)*† 214 (183, 252) 197 (148, 260) 178 (147, 216) 162 (127, 208) 0.124
Body mass index* 23.8 (23.2, 24.3) 25.3 (24.3, 26.3) 31.0 (30.3, 31.7) 31.8 (30.9, 32.7) < 0.001a, b, c, d, e
Total cholesterol (mmol/L)* 5.11 ± 1.03 5.71 ± 1.13 4.99 ± 0.93 5.62 ± 0.87 < 0.001a, c, d, f
HDL-C (mmol/L)* 1.58 ± 0.36 1.32 ± 0.36 1.40 ± 0.30 1.23 ± 0.27 < 0.001a, b, c, f
Glucose (mmol/L)* 4.90 (4.70, 5.30) 5.10 (4.80, 5.40) 5.20 (4.90, 5.50) 5.30 (4.90, 5.60) < 0.001b, c
Systolic blood pressure (mm Hg)* 111 (104, 122) 114 (107, 125) 119 (109, 131) 120 (113, 127) < 0.001b, c
Intima-media thickness (mm)*† 0.63 (0.62, 0.64) 0.66 (0.64, 0.69) 0.65 (0.64, 0.67) 0.65 (0.64, 0.67) < 0.001a, b, c
Total area (mm2)*† 15.60 (14.76, 16.46) 16.76 (15.27, 18.41) 16.53 (15.49, 17.65) 17.46 (16.05, 18.99) < 0.001c
Presence of plaque 75 (44.6%) 24 (42.1%) 52 (44.4%) 37 (52.9%) 0.595
*Age adjusted, presented as mean (95%CI), †geometric means; age presented as mean ± SD; Differences in continuous variables across categories of HTGW
components variable explored by general linear modelling. Categorical variables presented as n (%). Associations between categorical variables and HTGW
components variable explored by Chi-square test.
Pairwise comparisons: ap < 0.05, Normal WC/Normal TG vs. Elevated TG/Normal WC; bp < 0.05, Normal WC/Normal TG vs. Elevated WC/Normal TG; cp < 0.05,
Normal WC/Normal TG vs. HTGW; dp < 0.05, Elevated TG/Normal WC vs. Elevated WC/Normal TG; ep < 0.05, Elevated TG/Normal WC vs. HTGW; fp < 0.05, Elevated
WC/Normal TG vs. HTGW.
**Elevated waist circumference (WC) was ≥ 85 cm. Elevated triglyceride (TG) levels were ≥ 1.5 mmol/L. Six female participants are missing data for one or both
hypertriglyceridemic waist (HTGW) components.
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with TG when screening for individuals at increased car-
diometabolic risk is due to a fact that not all individuals
with increased WC have elevated VAT and are at in-
creased risk for CAD (14). Indeed, it has been shown that
isolated increase in WC or isolated hypertriglycerideamia
showed no association with increase in CAD risk, while
simultaneous presence of elevated WC and fasting TG
(HTGW) was associated with a significant increase in
CAD disease (13). Additionally, although cardiovascular
risk of men was significantly higher than that of women in
our study, which is most likely due to differences in body
fat accumulation between sexes [37,38], greatest athero-
sclerosis was observed in both men and women with
HTGW compared to their counterparts with isolated ele-
vated WC or TG. Thus, simultaneous measurement and
interpretation of WC and fasting TG can be a powerful
tool to identify both men and women characterized by
the atherogenic triade (hyperinsulinemia, elevated apo-
lipoprotein B, and small, dense LDL-C) and at high risk
for CAD (13, 27).
The strength of our study lies in exploring the associ-
ation between HTGW and subclinical atherosclerosis in
an apparently healthy and a multiethnic population, inusing several markers of subclinical atherosclerosis (IMT,
total area and presence of carotid plaques), and exploring
whether the effect of HTGW on subclinical atheroscler-
osis persists over and above traditional risk factors for
atherosclerosis. Our findings that HTGW phenotype is
associated with subclinical atherosclerosis in apparently
healthy men and women, irrespective of ethnicity, suggests
an important role that HTGW may play in primary care
practice in identifying patients at risk for atherosclerosis.
The use of HTGW would largely expedite and simplify
triaging of patients by identifying those “in need” of ag-
gressive atherosclerosis prevention, thereby decreasing the
amount of time and complex testing a primary health care
practitioner would spend screening for such patients and
potentially translate in lower health care costs. Moreover,
this quick assessment would further allow a primary care
health practitioner to spend more time in counselling a
patient on how to decrease their risk for atherosclerosis.
Patients seen by specialists often already have documen-
tation of traditional risk factors and so further assessment
for HTGW may not necessarily add information toward
atherosclerosis risk since we observed the effect of HTGW
on subclinical atherosclerosis was no longer significant
once all traditional atherosclerosis risk factors were added
AB
C
Figure 1 The association between HTGW phenotype and
indices of subclinical atherosclerosis in men. Panel A: The
association HTGW phenotype and IMT; Panel B: The association
between HTGW phenotype and total area; Panel C: The association
between HTGW phenotype and presence of plaques; ↑TG: Elevated
triglycerides, not elevated waist circumference; ↑WC: Elevated waist
circumference, not elevated triglycerides; HTGW: elevated both
triglycerides and waist circumference; _1: Model 1, adjusted for age,
ethnicity, smoking and physical activity; _2: Model 2 = Model 1 +
additional adjustment for systolic blood pressure, total cholesterol,
HDL-C, fasting blood glucose, family history of CVD, and BMI;
B (95%CI): Beta unstandardized regression coefficient with a
corresponding 95 percent confidence interval; OR (95%CI): odds
ratio with a corresponding 95 percent confidence interval;
*p < 0.05, **p < 0.01, ***p < 0.001.
A
B
C
Figure 2 The association between HTGW phenotype and
indices of subclinical atherosclerosis in women. Panel A: The
association HTGW phenotype and IMT; Panel B: The association
between HTGW phenotype and total area; Panel C: The association
between HTGW phenotype and presence of plaques; ↑TG: Elevated
triglycerides, not elevated waist circumference; ↑WC: Elevated waist
circumference, not elevated triglycerides; HTGW: elevated both
triglycerides and waist circumference; _1: Model 1, adjusted for age,
ethnicity, smoking and physical activity; _2: Model 2 = Model 1 +
additional adjustment for systolic blood pressure, total cholesterol,
HDL-C, fasting blood glucose, family history of CVD, and BMI;
B (95%CI): Beta unstandardized regression coefficient with a
corresponding 95 percent confidence interval; OR (95%CI): odds
ratio with a corresponding 95 percent confidence interval; *p < 0.05,
**p < 0.01, ***p < 0.001.
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HTGW with cardiometabolic risk factors [12,13,24-28]
and its ability to predict cardiovascular disease event
[30], HTGW may be used as a simple and inexpensive
tool in clinical practice to monitor patients’ changes(improvement/deterioration) in cardiometabolic risk.
Additionally, this simple tool could also provide greater
incentive to patients for lifestyle change, as they can easily
track the effect of lifestyle changes on their cardio-
metabolic risk.
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at increased risk for atherosclerosis, the widespread use
of HTGW as a screening tool may be limited due to the
lack of routine measurement of WC in clinical practice.
Indeed, in a recently published study, Gupta et al. (2012)
surveyed Canadian primary care physicians and found
that WC was routinely measured by only 6% of physicians
[39]. This finding contrasts with the knowledge that 80%
of surveyed physicians considered WC to be a vital sign
[39]. This discrepancy may be due to a notion amongst
clinicians that WC is a tool for research purposes only;
a lack of effort to continuously inform physicians about
the clinical usefulness of the routine WC measurements;
and a lack of a standardized protocol for WC measure-
ment [40]. There is a concern that a lack of standardized
protocol for measurement of WC may influence clinical
decision-making [41-43]. However, it has been reported
that the reproducibility of WC measurement is high re-
gardless of the measurement site [44] and that the WC
measurement protocol has no significant influence on the
association of WC with CVD, diabetes, all-cause and CVD
mortality. Given the simplicity, high reproducibility of and
low costs associated with the WC measurement, it has
been argued that WC should be used by the medical com-
munity more consistently [28].
Ethnic-specific WC targets may pose an additional chal-
lenge in identifying individuals with HTGW and hence at
risk for atherosclerosis [17]. While using current definition
for HTGW [22], we found that ethnicity did not modify the
association between HTGW and indices of atherosclerosis;
however, our results indicate significant ethnic differences
in the distribution of HTGW components which is most
likely driven by body fat accumulation shown to be differ-
ent in distinct ethnic groups [45,46]. Thus, we believe
that further exploration on the role of ethnicity in the
association between HTGW and subclinical athero-
sclerosis is warranted given the already established eth-
nic differences in CVD risk [47,48].
There are limitations to the study design as it is cross-
sectional rather than prospective. Future research should
employ a prospective study design to determine causal
relationships. Our study sample may not be representative
of a general population given that our participants were
between ages of 30 and 65 and purposely recruited across
a range of BMI values. However, this approach to recruit-
ment may be advantageous, as it allowed us to explore the
association between HTGW and atherosclerosis in a
population with diverse body sizes. Furthermore, due to a
difficulty in identifying individuals of Chinese origin with
BMI of 30 and higher, the target for the upper BMI range
of Chinese individuals was changed to a BMI of 28 or
higher. However, we believe that this slight modification
in the recruitment strategy did not influence our study re-
sults where Chinese individuals were shown to have lowerprevalence of HTGW and hence lower cardiovascular risk
compared to their ethnic counterparts; as already reported
in the literature [48,49].
Conclusions
In conclusion, in a multi-ethnic population of apparently
healthy individuals, in both men and women, the presence
of HTGW was positively associated with subclinical athero-
sclerosis as depicted by carotid IMT and total area indices
after adjustment for age, ethnicity, smoking and physical
activity. However, in our study, HTGW did not show the
association with subclinical atherosclerosis over and above
the traditional risk factors for atherosclerosis. Our results
further verify the importance of HTGW as a simple clinical
tool that may serve as an early marker of subclinical athero-
sclerosis in men and women, irrespective of ethnicity. The
implementation of HTGW as a preventative clinical tool
would allow for timely implementation of prevention pro-
grams to reduce subclinical atherosclerosis and future CVD
risk. However, once individuals are assessed for all trad-
itional risk factors for atherosclerosis, the results of our
study indicate that the additional assessment of men and
women for HTGW is not warranted.
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